TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 184 filers reported holding TG THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.79 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $72,000 | -76.7% | 12,200 | +31.1% | 0.00% | -50.0% |
| Q3 2021 | $309,000 | -14.2% | 9,305 | 0.0% | 0.00% | -33.3% |
| Q2 2021 | $360,000 | -19.6% | 9,305 | +0.2% | 0.00% | -25.0% |
| Q1 2021 | $448,000 | -7.2% | 9,285 | 0.0% | 0.00% | -20.0% |
| Q4 2020 | $483,000 | +107.3% | 9,285 | +6.7% | 0.01% | +66.7% |
| Q3 2020 | $233,000 | +12.0% | 8,700 | -18.7% | 0.00% | 0.0% |
| Q2 2020 | $208,000 | – | 10,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,890,000 | $15,800,400 | 5.14% |
| Ghost Tree Capital, LLC | 1,000,000 | $8,360,000 | 2.75% |
| Soleus Capital Management, L.P. | 2,884,382 | $24,113,434 | 2.22% |
| M28 Capital Management LP | 216,600 | $1,810,776 | 2.08% |
| Paradigm Biocapital Advisors LP | 3,619,015 | $30,254,965 | 2.05% |
| 683 Capital Management, LLC | 1,350,000 | $11,286,000 | 0.88% |
| Parkwood LLC | 165,414 | $6,081 | 0.66% |
| Spotlight Asset Group, Inc. | 79,000 | $660,440 | 0.60% |
| Pier Capital, LLC | 392,709 | $3,283,047 | 0.53% |
| Quantum Private Wealth, LLC | 91,081 | $761,438 | 0.36% |